eXTReMe Tracker
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

International Consortium

Related Links

Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold

Posted on: 10 June 2018, source: Bloomberg
Crispr Therapeutics AG plunged after the gene-editing company said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by U.S. regulators. Crispr is developing the therapy with Vertex Pharmaceuticals Inc., and the trial had yet to begin. The companies said in a statement Wednesday that the Food and Drug Administration placed a halt on the experiment until the agency could get more information from the companies.



“We’re working with the FDA and will respond as soon as we can about whatever questions they have regarding the trial,” Crispr spokesman Chris Erdman said by phone. Erdman said the company didn’t think the hold would affect its trial in Europe for patients with beta-thalassemia, another blood disorder.

Editas Medicine Inc. and Intellia Therapeutics Inc., which are also developing gene-therapy treatments, fell after hours as well.

Read full story »
Posted on: 10 June 2018, source: Bloomberg
Crispr Therapeutics AG plunged after the gene-editing company said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by U.S. regulators. Crispr is developing the therapy with Vertex Pharmaceuticals Inc., and the trial had yet to begin. The companies said in a statement Wednesday that the Food and Drug Administration placed a halt on the experiment until the agency could get more information from the companies.
{fastsocialshare}
{{Google468x60Tekst}}

Register to read more ...